Impact BioMedical, Inc. (IBO) earnings · rev $32.0K
These earnings events as JSON? API free 100/dayImpact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
This IBO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IBO revenue for 2025-12-31 was $32.0K. Net income was -$11.8M. Revenue was down 36.0% from 2022-12-31 to 2025-12-31. IBO currently screens at market cap $7.6M.
When the next IBO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 36.0% from 2022-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full IBO research stays on the stock page; the tape stays on the quote page.
IBO earnings FAQ
What are IBO's latest revenue and net income?
Latest cached Impact BioMedical, Inc. (IBO) revenue for Dec 31, 2025 was $32.0K. Net income was -$11.8M. Statements: https://lician.com/financials/ibo
What is IBO's latest diluted EPS?
Latest cached Impact BioMedical, Inc. (IBO) diluted EPS for Dec 31, 2025 was -$0.38.
What period does the latest IBO earnings print cover?
The latest cached Impact BioMedical, Inc. (IBO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2022.
How did IBO revenue change from the prior cached period?
Cached Impact BioMedical, Inc. (IBO) revenue was down 36.0% from $50.0K (Dec 31, 2022) to $32.0K (Dec 31, 2025). Statements: https://lician.com/financials/ibo
Where are IBO earnings listed?
Cached earnings facts for Impact BioMedical, Inc. (IBO) are listed at https://lician.com/earnings/ibo. Statements: https://lician.com/financials/ibo
Not investment advice.